24 Apr 2020 – DB Schenker COVID19 Response Conference.
COVID19 briefs for DB Schenker: Importance of prevention and hygiene practices.
This was an invited lecture for COVID19 response call hosted by DB Schenker Singapore and its customers at the start of the global COVID19 pandemic on 24 Apr 2020, covering the topics of threat assessment, future course forecast, plausibility assessment on the discussed response measures, and our recommended prevention measures (read).
Dr Chung, J. F.
Xylonix peer-reviewed publications and public presentations on topics of next-gen cancer immunotherapies, COVID19 endemic crisis & response, and on ageing immunity.
24 Sep 2020 – Translational Oncology Summit
Fast tracking C010DS Zn: PARP1 agonist targeting cancer and M2-like macrophages.
This was an invited lecture at Translational Oncology Summit, hosted by Champions Oncology. This is the first disclosure event where we expressed our view on the resemblance between the macrophages of advanced cancers and the COVID-reprogrammed macrophages, predicted the future risks of poorer cancer prognosis, and proposed the dysfunctional macrophages as the therapeutic targets for treating the future aggressive cancers and post-COVID syndromes. (read).